Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arbutus Biopharma

3.34
+0.04501.37%
Volume:224.09K
Turnover:747.38K
Market Cap:638.59M
PE:-8.78
High:3.37
Open:3.31
Low:3.31
Close:3.29
Loading ...

GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium

Business Wire
·
25 Apr

Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know

Zacks
·
24 Apr

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

GlobeNewswire
·
23 Apr

Arbutus Biopharma Down Over 8%, on Pace for Largest Percent Decrease Since April 2023 -- Data Talk

Dow Jones
·
07 Apr

All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy

Zacks
·
01 Apr

Arbutus Biopharma Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Arbutus Biopharma Shares up 1.5% Premarket After FY Revenue Beat, Co Reduces Workforce by 57%

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Cuts Workforce by More Than Half, Hires New CFO in Exec Shuffle

Dow Jones
·
27 Mar

Arbutus Biopharma FY 2024 GAAP EPS $(0.38) Up From $(0.44) YoY, Sales $6.17M Down From $18.14M YoY

Benzinga
·
27 Mar

BRIEF-Arbutus Biopharma FY Revenue USD 6.2 Million Vs. IBES Estimate USD 6.18 Million

Reuters
·
27 Mar

Arbutus Biopharma Corp: Jury Trial in Moderna U.S. Mrna-Lnp Vaccine Litigation Scheduled for September 2025

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma FY Cash & Investments USD 122.6 Million

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Corp - Terminates Atm Program and Reduces Workforce by 57% in Q1 2025

THOMSON REUTERS
·
27 Mar

Arbutus Biopharma Corp - Appoints Tuan Nguyen as CFO

THOMSON REUTERS
·
27 Mar

Press Release: Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Dow Jones
·
27 Mar

As Vaccine Skepticism Mounts, Moderna's Business Grows More Precarious -- Barrons.com

Dow Jones
·
27 Mar

GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis

Zacks
·
24 Mar

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts

Business Wire
·
20 Mar

Arbutus Biopharma Corp expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
14 Mar

Strategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges

TIPRANKS
·
04 Mar